Physician profile
Eric Saunders
NPI 1477555274
$1,473.30
in general payments reported to CMS, 2019-2025
19 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.79 · 2021: $23.93 · 2022: $226 · 2023: $294 · 2024: $449 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $266.77 | 2022-2025 | Spaceoar Vue System - 10ml |
| Pfizer INC. | $180.77 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $178.57 | 2022-2025 | Imfinzi |
| Blue Earth Diagnostics | $167.75 | 2022-2025 | Posluma |
| Sumitomo Pharma America, INC. | $103.94 | 2024-2025 | Orgovyx |
| Novartis Pharmaceuticals Corporation | $83.44 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $79.75 | 2022 | |
| Myriad Genetic Laboratories, INC. | $63.32 | 2024 | Prolaris, Myrisk |
| Merck Sharp & Dohme LLC | $56.26 | 2024-2025 | Keytruda |
| Asd Specialty Healthcare, LLC | $49.79 | 2019 | |
| Imperative Care, INC | $43.50 | 2025 | Symphony Catheter |
| Johnson & Johnson Surgical Vision, INC. | $34.33 | 2025 | Tecnis Iol, Catalys System |
| Stryker Corporation | $32.31 | 2025 | Optablate |
| Sun Pharmaceutical Industries INC. | $26.38 | 2024 | |
| Dendreon Pharmaceuticals LLC | $23.93 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $23.63 | 2024 | Erleada |
| Becton, Dickinson and Company | $20.87 | 2025 | Trek |
| Telix Pharmaceuticals | $19.10 | 2023 | Illuccix |
| Ge Healthcare | $18.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.